DK0774119T3 - Oligomere bæremolekyler med på defineret måde indföjede markeringsgrupper og haptener - Google Patents

Oligomere bæremolekyler med på defineret måde indföjede markeringsgrupper og haptener

Info

Publication number
DK0774119T3
DK0774119T3 DK95927713T DK95927713T DK0774119T3 DK 0774119 T3 DK0774119 T3 DK 0774119T3 DK 95927713 T DK95927713 T DK 95927713T DK 95927713 T DK95927713 T DK 95927713T DK 0774119 T3 DK0774119 T3 DK 0774119T3
Authority
DK
Denmark
Prior art keywords
haptenes
incorporated
carrier molecules
groups
oligomeric carrier
Prior art date
Application number
DK95927713T
Other languages
Danish (da)
English (en)
Inventor
Christoph Seidel
Hans-Peter Josel
Eva Hoess
Rupert Herrmann
Andreas Finke
Andreas Marschall
Original Assignee
Roche Diagnostics Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE4430998A external-priority patent/DE4430998A1/de
Application filed by Roche Diagnostics Gmbh filed Critical Roche Diagnostics Gmbh
Application granted granted Critical
Publication of DK0774119T3 publication Critical patent/DK0774119T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531—Production of immunochemical test materials
    • G01N33/532—Production of labelled immunochemicals
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531—Production of immunochemical test materials
    • G01N33/532—Production of labelled immunochemicals
    • G01N33/533—Production of labelled immunochemicals with fluorescent label
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54306—Solid-phase reaction mechanisms
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6878—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids in eptitope analysis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G01N33/743—Steroid hormones
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
    • C12N2770/24222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Biophysics (AREA)
  • Organic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Peptides Or Proteins (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
DK95927713T 1994-07-25 1995-07-24 Oligomere bæremolekyler med på defineret måde indföjede markeringsgrupper og haptener DK0774119T3 (da)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
DE4426276 1994-07-25
DE4430998A DE4430998A1 (de) 1994-07-25 1994-08-31 Metallchelat-markierte Peptide
DE4430973A DE4430973A1 (de) 1994-07-25 1994-08-31 Hapten-markierte Peptide
DE4439345A DE4439345A1 (de) 1994-07-25 1994-11-04 Oligomere Trägermoleküle mit definiert eingebauten Markierungsgruppen und Haptenen
PCT/EP1995/002915 WO1996003650A1 (de) 1994-07-25 1995-07-24 Oligomere trägermoleküle mit definiert eingebauten markierungsgruppen und haptenen

Publications (1)

Publication Number Publication Date
DK0774119T3 true DK0774119T3 (da) 2004-07-12

Family

ID=27436022

Family Applications (1)

Application Number Title Priority Date Filing Date
DK95927713T DK0774119T3 (da) 1994-07-25 1995-07-24 Oligomere bæremolekyler med på defineret måde indföjede markeringsgrupper og haptener

Country Status (12)

Country Link
EP (1) EP0774119B1 (ja)
JP (1) JP3923076B2 (ja)
CN (1) CN1178062C (ja)
AT (1) ATE261122T1 (ja)
CA (1) CA2195752C (ja)
DK (1) DK0774119T3 (ja)
ES (1) ES2217282T3 (ja)
FI (1) FI970299A (ja)
NO (1) NO970130D0 (ja)
NZ (1) NZ290810A (ja)
PT (1) PT774119E (ja)
WO (1) WO1996003650A1 (ja)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030078416A1 (en) * 1996-04-30 2003-04-24 Yitzhak Tor Substituted phenanthrolines
DE19780856D2 (de) 1996-08-16 1999-09-23 Roche Diagnostics Gmbh Kontrollsystem für die Überwachung der regelmäßigen Einnahme eines Medikamentes
FR2955111B1 (fr) 2010-01-12 2013-05-31 Biomerieux Sa Procede de preparation de composes polybiotinyles

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE42317T1 (de) * 1983-07-29 1989-05-15 Henning Berlin Gmbh Voraktivierte kunststoffoberflaechen zur immobilisierung von organisch-chemischen und biologischen materialien, verfahren zur herstellung und verwendung derselben.
US4748111A (en) * 1984-03-12 1988-05-31 Molecular Diagnostics, Inc. Nucleic acid-protein conjugate used in immunoassay
EP0155224A3 (en) * 1984-03-15 1987-05-06 CHROMAGENICS, Inc. Solid-borne complex bearing chromagen responsive functionality for antibody, antigen, receptor, or ligand detection
DK365785A (da) * 1984-09-17 1986-03-18 Hoffmann La Roche Metalcomplexer
US5106762A (en) * 1990-04-20 1992-04-21 Georgetown University Ligand-label conjugates which contain polyoxoanions of sulfur or phosphorus
CA2064972A1 (en) * 1991-04-03 1992-10-04 John Joseph Rejman Immunoassay for immunoglobulins

Also Published As

Publication number Publication date
NZ290810A (en) 1998-01-26
NO970130L (no) 1997-01-10
ES2217282T3 (es) 2004-11-01
JPH10506708A (ja) 1998-06-30
JP3923076B2 (ja) 2007-05-30
FI970299A0 (fi) 1997-01-24
EP0774119B1 (de) 2004-03-03
AU3164995A (en) 1996-02-22
CN1153555A (zh) 1997-07-02
ATE261122T1 (de) 2004-03-15
FI970299A (fi) 1997-01-24
CA2195752A1 (en) 1996-02-08
PT774119E (pt) 2004-07-30
NO970130D0 (no) 1997-01-10
WO1996003650A1 (de) 1996-02-08
CA2195752C (en) 2010-10-26
CN1178062C (zh) 2004-12-01
EP0774119A1 (de) 1997-05-21
AU682278B2 (en) 1997-09-25

Similar Documents

Publication Publication Date Title
DK0733069T3 (da) Oprensede Primat CTLA-8-antigener og beslægtede reagenser
DE69534778D1 (en) Cathepsin-02-protease
DE69020555T2 (de) Fällungstest für mikroorganismen.
AR243931A1 (es) Antigeno purificado,conjunto de reactivos para la deteccion de anticuerpos anti-hiv-2 en un fluido biologico que comprende dichos antigenos,anticuerpos,hibridomas y procedimientos.
DE69018537D1 (de) Zweistufiges Verfahren zum Herstellen starker, dünner Schlauchblasfolien.
DE69021742T2 (de) Verfahren zum Nachweis von kleinzelligem Carzinom und die Verwendung von Sequenzen, die Acylpeptid-Hydrolase codieren, für diesen zweck.
DE463085T1 (de) Riemenspannvorrichtung, spannvorrichtung und einzelteile dazu sowie verfahren zur herstellung.
FR2707994B1 (fr) Composites moléculaires de siloxane, procédé de préparation desdits composites, et leurs utilisations.
DE69002298T2 (de) Vakuumtrocknungsverfahren für Stückgüter und Vorrichtung zur Durchführung des Verfahrens.
DK0774119T3 (da) Oligomere bæremolekyler med på defineret måde indföjede markeringsgrupper og haptener
DE68908162T2 (de) Verfahren zur Herstellung von keramischen Produkten, insbesondere von keramischen Federn.
ES2236703T3 (es) Uso de metodos para identificar oligopeptidos de señal hidrofilos.
ATE122723T1 (de) Retinoblastoma-genprodukt-antikörper und deren verwendungen.
DE69108880D1 (de) Verfahren und Vorrichtung zum Herstellen von gebogen Glasscheiben.
ES2139714T3 (es) Fluororribosil-aminas anomericas.
DE3872648D1 (de) Alkanoylesterverbindungen, zwischenverbindungen dazu und verfahren zur herstellung.
TW223019B (ja)
ATE142342T1 (de) Benutzung von sp-2 monoklonalen antikörpern zur diagnostik und zur beobachtung des hiv- infektionsfortschritts
DE58906674D1 (de) Verfahren zur Auswahl produktiver, Aminosäuren ausscheidender Stämme von Mikroorganismen.
WO1996016077A3 (en) Reagent for quantifying free amine groups
HUT68517A (en) Process for diagnosing m.gallisepticum infection and identifying m.gallisepticum; process for producing m. gallisepticum specific monoclonal antibodies
UA31082A (uk) Спосіб прискорення біологічного дослідження на туберкульоз